Evidence map›Paper›PMID 41406225›Full record

ArticleScience advances2025

lncRNA LINC-PINT controls lymphatic function and inflammatory profile in lymphedema.

Nathalie Laugero, Claire Peghaire, Léna Verdu, Elisa Balzan, Tangra Draia-Nicolau, Roxane Sylvestre, Julie Malloizel-Delaunay, Alessandra Bura-Rivière, Florent Morfoisse, Anne-Catherine Prats and 2 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nathalie LaugeroI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.ORCID 0009-0002-1288-0263
Claire PeghaireI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.ORCID 0000-0003-3304-3018
Léna VerduI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.
Elisa BalzanI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.ORCID 0009-0004-9689-0390
Tangra Draia-NicolauI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.ORCID 0000-0001-5518-6170
Roxane SylvestreI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.
Julie Malloizel-DelaunayService de Médecine Vasculaire, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.ORCID 0000-0002-9836-5029
Alessandra Bura-RivièreService de Médecine Vasculaire, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Florent MorfoisseI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.ORCID 0000-0003-1532-3665
Anne-Catherine PratsI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.ORCID 0000-0002-5282-3776
Eric LacazetteI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.ORCID 0000-0003-1234-5260
Barbara Garmy-SusiniI2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.ORCID 0000-0001-6100-2294

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphedema is a lymphatic dysfunction leading to an accumulation of fluid and fat in the arm or leg. Here, we performed noncoding RNA profiling of human breast cancer-induced secondary lymphedema. We identified the long intergenic non-protein coding RNA, P53-induced transcript (

Indexed as

InflammationLymphedemaRNA, Long NoncodingAnimalsCell MovementCell ProliferationDisease Models, AnimalEndothelial CellsFemaleHumansLymphangiogenesisLymphatic VesselsMiceRNA, Long Noncoding

Identifiers

PMID41406225
PMCPMC12710707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.